Newmark Group, Inc. (NMRK)
Valuation Overview•Is Newmark Group, Inc. Overvalued or Undervalued?
Trading at a discount across both intrinsic cash flow and relative peer multiples, indicating a strong margin of safety.
Moderate quality score of 54/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Average quality business weighed down by significant profitability concerns.
Wall Street sentiment is generally neutral alongside robust expected earnings growth. This outlook is strongly supported by highly attractive capital returns, driven predominantly by aggressive share repurchases.
NMRK struggles with subpar profitability and pressured margins. However, the balance sheet carries elevated leverage, requiring careful monitoring of debt servicing capabilities.
The company demonstrates solid revenue growth (7.2% 3Y CAGR) paired with robust earnings compounding (14.8% EPS 3Y CAGR). Operating efficiency remains adequate with margins around 7.1%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $1.0B | +21.9% | +7.2% | +11.9% | +10.8% | |
| EBITDA | $172.6M | — | +5.7% | — | — | |
| Net Income | $68.0M | +106.1% | +14.9% | — | — | |
| EPS (Diluted) | $0.37 | +100.0% | +14.8% | +11.8% | — | |
| Free Cash Flow | $608.8M | +431.3% | -49.9% | — | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 98.6% | 98.2% | 98.9% | 99.5% |
| Operating Margin | 7.1% | 6.0% | 13.6% | 13.0% |
| Net Margin | 3.8% | 2.6% | 7.3% | 7.3% |
| FCF Margin | 4.7% | -3.4% | 5.9% | 1.4% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.27 | $0.33 | +22.2% | ||
| Q1'26 | $0.65 | $0.68 | +4.6% | ||
| Q4'25 | $0.41 | $0.42 | +2.4% | ||
| Q3'25 | $0.26 | $0.31 | +19.2% | ||
| Q2'25 | $0.19 | $0.21 | +10.5% | ||
| Q1'25 | $0.48 | $0.55 | +14.6% | ||
| Q4'24 | $0.30 | $0.37 | +23.3% | ||
| Q3'24 | $0.22 | $0.22 | +0.0% |
Total return is +33.4% (1Y), outperforming the benchmark by +8.4%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -11.8% | -21.1% | — |
| 1Y | +33.4% | +8.4% | +1.3% |
| 3YCAGR | +36.1% | +16.2% | +6.4% |
| 5YCAGR | +4.9% | -9.1% | +4.7% |
| 10YCAGR | +1.5% | -12.2% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Newmark Group, Inc. (NMRK) valuation, health, and returns.
Newmark Group, Inc. is estimated to be undervalued under our discounted cash flow framework. relative multiples indicate the stock is Cheap versus peers compared to industry peers. undervalued (implying +398.2% upside to DCF intrinsic value of $74.08)
Newmark Group, Inc. has multiple valuation anchors: DCF Intrinsic Value: $74.08 | Peer Relative Fair Value: $20.44 | Wall Street Analyst Target: $15.20 (implying +2.2% upside). A convergence of these signals offers higher conviction.
Newmark Group, Inc. displays fair financial health with a composite quality score of 54/100, supported by a Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 5.2%.
Newmark Group, Inc. pays a 0.6% dividend yield, covered by a 17% payout ratio with 0 years of growth, supplemented by a 4.6% buyback yield.
Newmark Group, Inc.'s current growth trajectory is Accelerating. The company achieved +21.9% 1Y revenue growth and +100.0% 1Y EPS growth, compared to its 3Y revenue CAGR of +7.2%.
Wall Street consensus is Buy based on 12 analysts, beating EPS expectations in 58% of recent quarters with a 7-quarter streak. The consensus price target represents a +2.2% change from current levels.
Investment risks for Newmark Group, Inc. include: -29.2% 1-year max drawdown. Volatility risk is characterized by a beta of 1.25x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.